Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranostics.
Xue S, Gafita A, Zhao Y, Mercolli L, Cheng F, Rauscher I, D'Alessandria C, Seifert R, Afshar-Oromieh A, Rominger A, Eiber M, Shi K. Xue S, et al. Among authors: gafita a. Eur J Nucl Med Mol Imaging. 2024 May 9. doi: 10.1007/s00259-024-06737-3. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38724653 Free article.
Treatment Response Imaging in Prostate Cancer.
Swiha M, Gafita A, Nguyen A, Emmett L. Swiha M, et al. Among authors: gafita a. PET Clin. 2024 Apr 25:S1556-8598(24)00024-5. doi: 10.1016/j.cpet.2024.03.009. Online ahead of print. PET Clin. 2024. PMID: 38670877 Review.
An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate Cancer.
Li Y, Imami MR, Zhao L, Amindarolzarbi A, Mena E, Leal J, Chen J, Gafita A, Voter AF, Li X, Du Y, Zhu C, Choyke PL, Zou B, Jiao Z, Rowe SP, Pomper MG, Bai HX. Li Y, et al. Among authors: gafita a. J Imaging Inform Med. 2024 Apr 8. doi: 10.1007/s10278-024-01104-y. Online ahead of print. J Imaging Inform Med. 2024. PMID: 38587770
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial.
Gafita A, Martin AJ, Emmett L, Eiber M, Iravani A, Fendler WP, Buteau J, Sandhu S, Azad AA, Herrmann K, Stockler MR, Davis ID, Hofman MS. Gafita A, et al. Eur Urol Oncol. 2024 Apr 6:S2588-9311(24)00085-3. doi: 10.1016/j.euo.2024.03.009. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38584037
Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
Farolfi A, Armstrong WR, Djaileb L, Gafita A, Hotta M, Allen-Auerbach M, Unterrainer LM, Fendler WP, Rettig M, Eiber M, Hofman MS, Hadaschik B, Herrmann K, Czernin J, Calais J, Benz MR. Farolfi A, et al. Among authors: gafita a. J Nucl Med. 2024 Mar 1;65(3):438-445. doi: 10.2967/jnumed.123.266391. J Nucl Med. 2024. PMID: 38238041
63 results